Inhibition of histone deacetylation enhances endotoxin-stimulated transcription but does not reverse endotoxin tolerance

Abstract

Covalent modification of histones and the subsequent remodeling of chromatin have emerged as important mechanisms in regulating gene expression. In particular, recent identification of the enzyme families responsible for the steady-state balance of histone acetylation has served to redefine our understanding of these modifications as fundamental biochemical processes regulating transcription. Current evidence suggests that histone acetylation correlates positively with gene activation, while histone deacetylation acts to repress transcription. In this study, we examined the role of histone modification in the inflammatory response to endotoxin. We focused on the endotoxin-stimulated expression of the interleukin-1β promoter and tested the hypotheses that persistent histone deacetylation was responsible for the decreased expression of this promoter observed after prolonged exposure to endotoxin, a manifestation of a phenomenon known as endotoxin tolerance. We found that histone deacetylase inhibitors enhanced endotoxin-stimulated transcription; however, deacetylation inhibitors could neither block the development of tolerance nor restore endotoxin sensitivity in a tolerant cell. Deacetylase inhibitors could not restore LPS-mediated transcription in tolerant cells. These results show that histone acetylation/deacetylation regulates, at least in part, the endotoxin-induced expression of inflammatory genes and that repressed transcription observed in endotoxin tolerance is not caused by enhanced activity of histone deacetylases.

References

Watson Rwg , Redmond HP , Bouchier-Hayes D. Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses .J Leukoc Biol 1994; 56: 95—103.

Munoz C. , Carlet J. , Fitting C. , Misset B. , Bleriot J-P. , Cavaillon J.M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747—1754.

McCall CE , Grosso-Wilmoth LM , LaRue K. , Guzman RN , Cousart SL Tolerance to endotoxin-induced expression of the interleukin 1 gene in blood neutrophils of humans and the sepsis syndrome. J Clin Invest 1993;91:853—861.

LaRue Kea , McCall CE A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med 1994; 180: 2269—2275.

Kremer J-P. , Jarrar D. , Steckholzer U. , Ertel W. Interleukin-1, -6 and tumor necrosis factor-α release is down-regulated in whole blood from septic patients. Acta Haematol 1996; 95: 268—273.

Yoza BK , Hu Jy-Q, Cousart SL , McCall CE. Endotoxin inducible transcription is repressed in endotoxin olerant cells. Shock 2000; 13: 236—243.

Baeuerle PA , Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141—179.

Dressel U. , Renkawitz R. , Baniahmad A. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer . Anticancer Res 2000; 20: 1017—1022.

Brown CE , Lechner T. , Howe L. , Workman JL

The many HATs of transcription coactivators. Trends Biol

Sci 2000; 25: 15—19.

10.

Kawasaki H. , Schiltz L. , Chiu R. et al. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 2000; 405: 195—200.

11.

Caput D. , Beutler B. , Hartog K. , Brown-Shimer S. , Cerami A. Identification of a common nucleotide sequence in the 3'untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986; 83:1670—1680.

12.

Nakamaki T. , Imamura J. , Brewer G. , Tsuruoka N. , Koeffler HP Characterization of adenosine-uridine-rich RNA binding factors. J Cell Physiol 1995; 165: 484—492.

13.

Bentley DL , Groudine M. Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 1988; 53: 245—256.

14.

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085—2088.

15.

Vogel SN , Johnson D. , Perera PY et al. Functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation . J Immunol 1999; 162: 5666—5670.

16.

Medvedev AE , Kopydlowski KM , Vogel SN Inhibition of lipopolysaccharide-induced signal transduction in endotoxintolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 2000; 164: 5564—5574.

17.

Li L. , Cousart S. , Hu J. , McCall CE Characterization of IRAK in normal and endotoxin tolerant cells. J Biol Chem 2000; 275: 23340—23345.

18.

Ziegler-Heitbrock Hwl , Wedel A. , Schraut W. et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers . J Biol Chem 1994; 269: 17001—17004.

19.

Bohrer H. , Qui F. , Zimmermann T. et al. Role of NF-κB in the mortality of sepsis. J Clin Invest 1997; 100: 972—985.

20.

Grant PA , Berger SL Histone acetyltransferase complexes. Semin Cell Dev Biol 1999; 10: 196—177.

21.

Gu W. , Roeder RG Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997; 90: 595—606.

22.

Strahl BD , Allis CD The language of covalent histone modifications. Nature 2000; 403: 41—45.

23.

Perissi V. , Dasen JS , Kurokawa R. et al. Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc Natl Acad Sci USA 1999; 96: 3652—3657.

24.

Gerritsen ME , Williams AJ , Neish AS , Moore S. , Shi Y. , Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 1997; 94: 2927—2932.

25.

Delgado M. , Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factorkappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J Biol Chem 2001; 276: 369—380.

26.

Merienne K. , Pannetier S. , Harel-Bellan A. , Sassone-Corsi P. Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities. Mol Cell Biol 2001; 21: 7089—7096.

27.

Saccani S. , Pantano S. , Natoli G. p38-dependent marking of inflammatory genes for increased NF-κB recruitment . Nat Immunol 2002; 3: 69—75.